Cytokinetics Announces New PDUFA Date for Aficamten in Obstructive Hypertrophic Cardiomyopathy - Cytokinetics ( NASDAQ:CYTK )
SOUTH SAN FRANCISCO, Calif., May 01, 2025 ( GLOBE NEWSWIRE ) -- Cytokinetics, Incorporated CYTK today announced that the U.S.
https://www.benzinga.com/pressreleases/25/05/g45150594/cytokinetics-announces-new-pdufa-date-for-aficamten-in-obstructive-hypertrophic-cardiomyopathy